Reata Pharmaceuticals Inc A (NASDAQ:RETA)

North American company
add to virtual portfolio
trade
This share can be held in
Trading AccountISAJISASIPP

Share Price Chart

- Chart currently unavailable -

Market Info - RETA

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info - RETA

  • Market Cap$6.520bn
  • SymbolNASDAQ:RETA
  • IndustryHealthcare
  • SectorBiotechnology
  • Currency
  • ISINUS75615P1030

Company Profile

Reata Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on identifying, developing, and commercializing therapeutics to address serious and life-threatening diseases by targeting molecular pathways. The company's product in the pipeline include bardoxolone methyl; Omaveloxolone and others.Reata Pharmaceuticals Inc is a clinical stage biopharmaceutical company engaged in identifying, developing, and commercializing product candidates to address rare and life-threatening diseases by targeting molecular pathways.

Latest RETA news

Currently there for this company. Visit our news hub for other news .